BlossomHill Therapeutics Statistics
NASDAQ: BLSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.61-0.68 (-3.93%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 16.34 -1.63%
BlossomHill Therapeutics by the numbers
BlossomHill Therapeutics has a market capitalization of $527.9 million based on 31.78M shares outstanding. With trailing EPS of $-4.70, BlossomHill Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.0% below its 50-day average and 16.0% below its 200-day average.
Average daily trading volume is 263.69K shares, or about $4.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BLSM valuation vs. peer median
| Metric | BLSM | Peer median | Difference |
|---|---|---|---|
| Market cap | $527.95M | $517.56M | +2% |
| Avg. volume | 263.69K | 594.74K | -56% |
Peer median across 8 companies: OCS, MPLT, NGNE, ALT, DRUG, EOLS, PBYI, PHAT.
Valuation
- Market cap
- $527.95M
- EPS (TTM)
- $-4.70
- Shares outstanding
- 31.78M
Price and trading
- Previous close
- 17.29
- Open
- 17.17
- Day range
- 16.12 – 17.67
- 52-week range
- 15.25 – 27.99
- Beta
- —
- Volume
- 253.80K
- Average volume
- 263.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 18, 2026
Additional statistics
- Market Cap
- 527.95M
- Forward Pe
- -4.20
- Eps
- -4.70
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.99
- Week52 Low
- 15.25
- Avg Volume
- 263.69K
- Shares Outstanding
- 31.78M
- Ma50
- 19.78
- Ma200
- 19.78
- Earnings Date
- Sep 18, 2026
- Pct From52w High
- -40.66%
- Pct From52w Low
- 8.92%